Drug profile · INN
tiagabine hydrochloride
TIAGABINE HYDROCHLORIDE
tiagabine hydrochloride (TIAGABINE HYDROCHLORIDE) is a gaba transporter 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — tiagabine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
tiagabine hydrochloride (TIAGABINE HYDROCHLORIDE) is a gaba transporter 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA transporter 1 inhibitor
Primary target: Sodium- and chloride-dependent GABA transporter 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is tiagabine hydrochloride?
tiagabine hydrochloride (TIAGABINE HYDROCHLORIDE) is a gaba transporter 1 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tiagabine hydrochloride?
TIAGABINE HYDROCHLORIDE is a marketed brand name for tiagabine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tiagabine hydrochloride?
tiagabine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.